Key result
Coronary microvascular disease is a common, underdiagnosed cause of angina requiring increased awareness and utilization of invasive assessment for appropriate diagnosis and management.
Answers are grounded in this paper and cite their sources.
Coronary microvascular disease is an underappreciated cause of chest pain that can be definitively diagnosed in the catheterization laboratory to guide targeted, albeit currently limited, therapies.
Coronary microvascular disease (CMD) is one of the commonest causes of cardiac chest pain. The condition is more prevalent in women, and incidence is known to increase with age, hypertension, and diabetes. The pathophysiological pathways are heterogenous and related to intrinsic vascular and endothelial dysfunction. Furthermore, this entity is known to be associated with adverse cardiovascular outcomes. Despite this, there is inertia amongst cardiologists to further evaluate patients with non-critical coronary artery disease and suspected CMD. With refinement in technology, we have now better understanding of CMD and invasive testing in the catheterization laboratory is a viable option for confirming the diagnosis of CMD. However, despite advances in diagnosing and stratifying this entity, therapeutic options remain limited and poorly defined. In this editorial, we will briefly focus on the pathophysiology and invasive assessment and therapeutic options available for CMD.
No takes yet. Share an insight, caveat, or question.
Bhogal et al. (2025) conducted an editorial in Coronary microvascular disease. Invasive assessment of coronary microvascular disease was evaluated. Coronary microvascular disease is a common, underdiagnosed cause of angina requiring increased awareness and utilization of invasive assessment for appropriate diagnosis and management.
Synapse has enriched 10 related papers. Consider them for comparative context: